On February 5, 2014, there was a patent about bacterial infection.Recommanded Product: 23256-42-0 The title of the patent was Compound veterinary drug preparation for treating enteritis type colibacillosis of poultry. And the patent contained the following:
The invention belongs to compound veterinary drug preparation for treating enteritis type colibacillosis of poultry. The preparation comprises the following components: neomycin sulfate, TMP lactate, and glutamine as main components, and adjuvants, wherein neomycin sulfate 3.25 weight%, TMP lactate 0.81 weight%, glutamine 10 weight%, the adjuvant is glucose, the ratio of adjuvant is 85.94 weight%. The veterinary composition is used for treating enteritis type colibacillosis of poultry. The processing technol. of the composition includes grinding and sieving each component, weighing accurately according to the required proportion, mixing for 25 min, inspecting the semi-finished product quality, packaging, and inspecting the finished product quality to obtain the final product. The invention has obvious curative effect on enteritis type colibacillosis, has low drug resistance, safety, and low toxicity, and has very good popularization and application value. The experimental process involved the reaction of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate(cas: 23256-42-0).Recommanded Product: 23256-42-0
The Article related to neomycin sulfate trimethoprim lactate glutamine powder colibacillosis, Pharmaceuticals: Formulation and Compounding and other aspects.Recommanded Product: 23256-42-0
Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia